All In Biotech

Drug Trial Radar · NCT04542473

Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children

Pancreatic Enzymes and Bile Acids: A Non-Antibiotic Approach to Treat Intestinal Dysbiosis in Acutely Ill Severely Malnourished Children

Last checked: Nov 20, 2026Latest source record: Feb 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

400

Actual

Start

Jul 1, 2021

Primary completion

Oct 31, 2023

Study completion Jun 30, 2024

Sponsor

Lead sponsor
University of OxfordAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Amsterdam; University of Toronto; University of Washington; Oregon Health and Science University; Kenya Medical Research Institute; Queen Elizabeth Central Hospital, Blantyre, Malawi; Makerere University; KEMRI-Wellcome Trust Collaborative Research Program; International Centre for Diarrhoeal Disease Research, Bangladesh
First posted
Sep 9, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 2 months, up to 59 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Children with severe malnutrition who are sick and admitted to hospitals have high mortality, usually because of infection. Malnourished children have more potentially harmful bacteria in their upper intestines than well-nourished children and this may contribute to inflammation in the gut and whole body. These bacteria may cross from the intestines to the bloodstream causing life-threatening infections. A related abnormality among malnourished children is reduction in the digestive enzymes made by the pancreas and the liver. Apart from helping with digestion of food, these enzymes are important in helping the body control bacteria in the upper intestines. It is therefore possible that treatment with digestive enzymes could help reduce the burden of harmful bacteria and thus lower inflammation and the risk of serious infection. One study conducted in Malawi has shown that children with severe malnutrition who were supplemented with pancreatic enzymes had a lower risk of dying. However, this was a small study and although promising, requires validation. No studies of supplementation with bile acids have been done among severely malnourished children. However, bile acids are commonly used to manage patients with liver function abnormalities, something that malnourished children suffer from as well. The investigators want to find out if supplementing these pancreatic enzymes and bile acids among ill children with severe acute malnutrition is safe and reduces the risk of death, deterioration or readmission to hospital.

Conditions

  • SEPSIS
  • MALNUTRITION, CHILD

Interventions

  • Pancreatic EnzymeDrug

    CREON micro 5000

  • Ursodeoxycholic acidDrug

    Ursodiol C24H40O4 suspension

  • Pancreatic Enzyme placeboOther

    Microcrystalline Cellulose,Macrogel 4000, Iron Oxide Yellow, Iron Oxide Red, Activated Charcoal.

  • Ursodeoxycholic acid placeboOther

    Sodium Citrate Dihydrate, Aspartame, Carboxymethylcellulose Sodium, Citric Acid Monohydrate, Dispersible Cellulose, Glycerol, Polysorbate-80, Saccharin Sodium,Sodium Benzoate, Sodium Methylparaben, Sodium Propylparaben

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MortalityTime frame: 60 days

Locations

4 sites in 4 countries. Site status is shown where the registry gives one.

  • ICDDR,B Dhaka Hospital

    Dhaka, Bangladesh

  • KEMRI WT Clinical Trials Facility

    Kilifi, Kenya

  • Queen Elizabeth Central Hospital

    Blantyre, Malawi

  • Mulago Hospital

    Kampala, Uganda

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.